InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-4.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Adams Kendra, Chief Financial Officer. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 12 disclosures have been published. Activity tracked since 18 September 2023. The latest transaction was filed on 18 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
6,250 shares0Common StockSEC:0001470831-25-000223:0
6,250 shares0Common StockSEC:0001470831-25-000223
1,863 shares@ US$3.2012.0% of flowCommon StockSEC:0001662579-25-000016:0
87,100 shares0Common StockSEC:0001662579-25-000016:1
4,559 shares@ US$3.1828.9% of flowCommon StockSEC:0001662579-25-000016:2
3,750 sharesCommon StockSEC:0001662579-24-000103:0
1,102 shares@ US$6.0412.9% of flowCommon StockSEC:0001662579-24-000103:1
1,837 shares@ US$6.3822.0% of flowCommon StockSEC:0001662579-24-000086:0
661 shares@ US$6.367.9% of flowCommon StockSEC:0001662579-24-000082:1
2,250 sharesCommon StockSEC:0001662579-24-000082:0
1,301 shares@ US$6.5316.4% of flowCommon StockSEC:0001662579-24-000014:0
25,000 shares0Common StockSEC:0001662579-23-000097:0
12 of 12 declarations
About Adams Kendra
Adams Kendra is the Chief Financial Officer at C4 Therapeutics, Inc. In this role, she is responsible for the company's financial management, including budgeting and financial analysis. Her expertise is crucial in ensuring the financial health of the organization.
